Blog Posts

SIO/ASCO Guideline for Integrative Therapies in GI Cancers

Society for Integrative Oncology/LinkedIn

Jul 30, 2025, 21:43

SIO/ASCO Guideline for Integrative Therapies in GI Cancers

Society for Integrative Oncology (SIO) shared a post on LinkedIn:

“Clinicians: the latest SIO/ASCO guideline helps you confidently recommend integrative therapies for your patients with GI cancers. Build trust with evidence.”

More posts featuring Society for Integrative Oncology.

cancer GI cancers OncoDaily Oncology Society for Integrative Oncology

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 24, 2025, 07:13

Olivier Elemento: AI in Hematology - A 2025 Snapshot from ASH

Insight

Aug 24, 2025, 07:09

Arturo LoAIza-Bonilla: Co-Authoring Insights on Large Language Models in Radiation Oncology

Drugs

Aug 24, 2025, 05:59

Lonsurf (Trifluridine/Tipiracil): A Patient’s Guide 2025 to Treatment for Advanced Colorectal and Stomach Cancer

Drugs

Aug 24, 2025, 05:22

Lonsurf (trifluridine/tipiracil) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More

Blog Posts

Aug 24, 2025, 05:05

Naveen Pemmaraju: Wonderful to Meet Friends and Colleagues at MPN meeting 2025

Insight

Aug 24, 2025, 04:55

Shilpa Gupta Shared Highlights from IBCG 2025

Voices

Aug 24, 2025, 03:00

Giuseppe Minniti: Gliofocus Phase 3 Trial Explores PARP Inhibitors with Radiotherapy in GBM

Voices

Aug 24, 2025, 01:32

Minhua Chu: Zelgen Biopharma’s ZGGS34 Gets FDA Approval for Solid Tumor Study

Insight

Aug 24, 2025, 01:13

Discovering Approaches to Enhance CAR-NK Cell Antitumor Activity with CRISPR - MD Anderson Cancer Center

Voices

Aug 23, 2025, 23:27

Lauren Kriger Groner: Filming the Cracking Cancer Podcast with The White Ribbon Project

Voices

Aug 23, 2025, 22:57

Paolo Tarantino: Exploring IO and ADC Combinations at SITC25

Drugs

Aug 23, 2025, 22:35

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen